Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| UNITED STATES | 106.0 | 120.2 | 112.5 | |
| Anesthesia Services | 97.7 | 110.3 | 101.8 | |
| Commercial Insurers | 79.6 | 90.3 | 87.0 | |
| Federal Insurers | 17.7 | 19.4 | 14.2 | |
| Total revenues | 106.2 | 120.4 | 112.7 | 95.0 |
| Revenue growth [+] | -11.8% | 6.8% | 18.7% | |
| UNITED STATES | -11.8% | 6.8% | | |
| Anesthesia Services | -11.4% | 8.4% | | |
| Commercial Insurers | -11.9% | 3.8% | | |
| Federal Insurers | -8.7% | 36.2% | | |
| Product Sales | -15.8% | -8.0% | | |
| Cost of goods sold | 112.9 | 105.7 | 92.5 | 74.2 |
| Gross profit | -6.8 | 14.7 | 20.3 | 20.8 |
| Gross margin | -6.4% | 12.2% | 18.0% | 21.9% |
| Selling, general and administrative | 27.0 | | | |
| Equity in earnings | 0.0 | 1.8 | | |
| Other operating expenses | -54.0 | | | |
| EBITDA [+] | 60.9 | 51.5 | 51.8 | 44.7 |
| EBITDA growth | 18.3% | -0.6% | 16.0% | |
| EBITDA margin | 57.4% | 42.7% | 45.9% | 47.0% |
| Depreciation | 0.2 | 0.1 | 0.1 | 0.1 |
| EBITA | 60.7 | 51.3 | 51.7 | 44.6 |
| EBITA margin | 57.2% | 42.7% | 45.8% | 46.9% |
| Amortization of intangibles | 40.5 | 34.9 | 31.4 | 23.7 |
| EBIT [+] | 20.2 | 16.4 | 20.3 | 20.8 |
| EBIT growth | 23.0% | -19.0% | -2.5% | |
| EBIT margin | 19.1% | 13.7% | 18.0% | 21.9% |
| Non-recurring items [+] | 27.0 | | | |
| Asset impairment | 27.0 | | | |
| Other income (expense), net | -23.7 | -6.6 | -4.6 | 5.5 |
| Pre-tax income | -30.5 | 9.8 | 15.7 | 26.3 |
| Income taxes | -7.5 | 1.6 | 2.7 | 7.2 |
| Tax rate | 24.8% | 16.5% | 17.2% | 27.2% |
| Minority interest | 1.6 | 4.4 | 8.3 | 7.1 |
| Net income | -24.5 | 3.8 | 4.7 | 12.1 |
| Net margin | -23.1% | 3.1% | 4.2% | 12.7% |
| |
| Basic EPS [+] | ($0.34) | $0.05 | $0.06 | $0.16 |
| Growth | -749.0% | -18.2% | -60.7% | |
| Diluted EPS [+] | ($0.34) | $0.05 | $0.06 | $0.16 |
| Growth | -759.6% | -17.9% | -60.7% | |
| |
| Shares outstanding (basic) [+] | 71.5 | 71.5 | 72.6 | 73.7 |
| Growth | 0.0% | -1.4% | -1.5% | |
| Shares outstanding (diluted) [+] | 71.5 | 72.7 | 74.1 | 75.1 |
| Growth | -1.6% | -1.9% | -1.3% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|